Bill
S 1755
Overview: S 1755 is a bill that requires clinical trials that apply for state grant funding to make certain information about such clinical trials public.Purpose and Intent: The ma
Overview: S 1755 is a bill that requires clinical trials that apply for state grant funding to make certain information about such clinical trials public.
Purpose and Intent: The main goal of this bill is to increase transparency and public access to information about clinical trials that receive state funding. The intent is to provide patients, researchers, and the general public with more information about the clinical trials being conducted in the state.
Key Provisions:
- Requires clinical trials that apply for state grant funding to publicly disclose information about the trial, including the study design, eligibility criteria, and expected outcomes
- Mandates the creation of a publicly accessible database or registry to house the disclosed information
- Allows the state health department to establish additional reporting requirements for grant-funded clinical trials
Affected Parties and Impacts: The primary affected parties are the researchers and organizations conducting clinical trials that receive state funding. They would be required to publicly disclose information about their trials, which could impact their ability to recruit participants or protect proprietary information. Patients and the general public would benefit from increased access to information about clinical trials in the state.
Procedural and Timeline Considerations: The bill has been referred to the Health committee and is currently under consideration. If passed, the new public disclosure requirements would likely take effect within a specified timeframe, such as 6 months or 1 year, to allow clinical trial organizers to comply with the new regulations.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
